More robust assays. Months off drug discovery.
Synthace's specialists have spent 20+ years building expertise and software for running the most effective experiments in assay development.
Request a demoYour drug discovery team is trying to move faster, but can't.
- Functions like assay development involve doing lots of different experiments, with lots of different variables—so they're hard to automate and make high throughput.
- Constant pressure doesn't give scientists the space to adopt smarter methods. To deliver, they'll default to older ways of working, and projects will take longer.
- In-house tools designed to streamline processes can actually tie up existing resources, because they're hard to use, maintain, and adapt.
Together, we help your scientists cut time to insight.
With our software, training, and on-site support from our specialists like Ross and Erika, we give your scientists a smarter, faster way to do experiments.
Ross Kent
Global Manager, Field Application Scientists
Ross heads up the Field Application Scientists team at Synthace. Ross has been a passionate supporter for using multifactorial methods in biological research, and uses his own first-hand experience to help others apply it to their lab work. He educates scientists across the industry, then works closely with them to implement those methods and automation into existing projects and programs.
Ross' background is molecular biology, with experience in industrial and academic R&D. He has held positions at Syngenta, where he worked as an automation scientist, the University of Manchester, and Royal Dutch Shell in Houston Texas. He earned his PhD in Synthetic Biology from the University of Manchester, focusing on applying multifactorial methods and machine learning to the optimization and design of gene expression circuits.
Erika Wiseman
Field Application Scientist
Erika is a Field Application Scientist dedicated to helping Synthace customers apply multivariate methods to their research. She taps into her wealth of experience across assay development to deeply understand scientists’ current processes, before helping them get the best possible insights, in the least number of experiments.
Erika's deep expertise comes from over 17 years' experience across industry and academia. During her time at Kalypsys and Dart NeuroScience, she focused on lead discovery—from developing and optimizing biochemical and cellular assays for high throughput screening, to lead optimization. Additionally, at King's College London, she specialized in high content imaging and "big data" bioinformatic analysis, and at Scripps Research, she worked on antibody engineering, molecular biology, and immunology.
-
We deliver a few starter projects.
We've witnessed countless success stories with our approach. But we know you'll want to apply it to your own science first. So, we help you identify a few impactful projects for us to deliver straight away. -
We give you the right tools and knowledge.
First, we help one team adopt our tried-and-tested methods for designing experiments with lots of variables—and we show your team how to automate them with Synthace’s software. -
We help you scale organization-wide.
Then, we apply this same approach across your drug discovery teams. We help your scientists become self-sufficient over time, so you continue getting faster, definitive results.
Keep control of projects, from start to finish.
Our specialists become extended members of your in-house discovery teams. They lend your scientists our decades of experience, and your scientists run the experiments.
Create a path to standardized insight.
Synthace's software structures your scientists' approach to experimentation, so you get reliable outputs for better go / no go decisions, every time.
See results from the first experiment.
No waiting around to realize value. The Synthace team uses the scientists and dispensers you’ve already got in your lab from day one to effect change and deliver projects to deadline.
But don’t just take our word for it.
Using Synthace has changed the way we do experiments, but more interestingly the way we think and communicate.
Helena Peilot SjögrenPrincipal Scientist, AstraZeneca
Synthace has enhanced the scientific questions we can explore. We’ve increased our experimental throughput by over tenfold. Their exceptional customer support and commitment to education have also been invaluable.
Keara Sutherland, Virica BiotechAssociate Scientist
Synthace allows us to make it routine for us to walk away from creating 24-48 constructs so our scientists can focus on other tasks
Karen BuntingDirector of Protein Sciences, Ipsen
Synthace allows us to think outside the box, and do things we couldn't do before.
André RaposoGroup Lead - Computer-Aided Biology (CAB) group at Oxford Biomedica